A detailed history of Amf Tjanstepension Ab transactions in Biogen Inc. stock. As of the latest transaction made, Amf Tjanstepension Ab holds 63,933 shares of BIIB stock, worth $9.53 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
63,933
Previous 63,933 -0.0%
Holding current value
$9.53 Million
Previous $12.4 Million -0.0%
% of portfolio
0.09%
Previous 0.09%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

BUY
$190.52 - $236.72 $3.83 Million - $4.75 Million
20,084 Added 45.8%
63,933 $14.8 Million
Q2 2023

Jul 05, 2023

SELL
$275.25 - $318.06 $494,349 - $571,235
-1,796 Reduced 3.93%
43,849 $12.5 Million
Q3 2022

Oct 26, 2022

SELL
$194.69 - $268.46 $4.84 Million - $6.67 Million
-24,854 Reduced 35.25%
45,645 $12.2 Million
Q2 2022

Jul 26, 2022

SELL
$187.54 - $223.02 $6.21 Million - $7.39 Million
-33,134 Reduced 31.97%
70,499 $14.4 Million
Q1 2022

May 05, 2022

SELL
$193.77 - $244.14 $166,448 - $209,716
-859 Reduced 0.82%
103,633 $21.8 Million
Q4 2021

Feb 08, 2022

BUY
$223.92 - $287.77 $2.06 Million - $2.65 Million
9,209 Added 9.66%
104,492 $25.1 Million
Q3 2021

Nov 03, 2021

BUY
$282.99 - $369.05 $3.72 Million - $4.85 Million
13,131 Added 15.98%
95,283 $27 Million
Q2 2021

Aug 11, 2021

SELL
$259.0 - $414.71 $4.82 Million - $7.72 Million
-18,612 Reduced 18.47%
82,152 $28.4 Million
Q4 2020

Feb 02, 2021

BUY
$236.26 - $355.63 $4.41 Million - $6.64 Million
18,682 Added 22.76%
100,764 $24.7 Million
Q3 2020

Nov 09, 2020

SELL
$264.77 - $305.71 $84,726 - $97,827
-320 Reduced 0.39%
82,082 $23.3 Million
Q2 2020

Aug 13, 2020

BUY
$258.66 - $342.55 $2.05 Million - $2.72 Million
7,936 Added 10.66%
82,402 $22 Million
Q1 2020

Apr 14, 2020

SELL
$268.85 - $341.04 $14.7 Million - $18.6 Million
-54,495 Reduced 42.26%
74,466 $23.6 Million
Q4 2019

Feb 12, 2020

SELL
$220.06 - $304.07 $2.83 Million - $3.91 Million
-12,846 Reduced 9.06%
128,961 $38.3 Million
Q3 2019

Oct 29, 2019

BUY
$217.44 - $243.88 $3.48 Million - $3.9 Million
15,988 Added 12.71%
141,807 $33 Million
Q2 2019

Jul 11, 2019

BUY
$219.29 - $241.72 $6.11 Million - $6.74 Million
27,879 Added 28.47%
125,819 $29.4 Million
Q1 2019

May 14, 2019

SELL
$216.71 - $338.96 $16.1 Million - $25.2 Million
-74,344 Reduced 43.15%
97,940 $23.2 Million
Q4 2018

Jan 30, 2019

SELL
$278.5 - $352.75 $6.37 Million - $8.07 Million
-22,880 Reduced 11.72%
172,284 $51.8 Million
Q3 2018

Nov 14, 2018

SELL
$293.51 - $383.83 $6.94 Million - $9.08 Million
-23,655 Reduced 10.81%
195,164 $69 Million
Q2 2018

Aug 13, 2018

SELL
$257.52 - $306.91 $4.05 Million - $4.83 Million
-15,736 Reduced 6.71%
218,819 $63.5 Million
Q1 2018

May 10, 2018

SELL
$260.13 - $367.91 $2.37 Million - $3.36 Million
-9,129 Reduced 3.75%
234,555 $64.2 Million
Q4 2017

Feb 13, 2018

BUY
$307.64 - $344.58 $3.58 Million - $4.01 Million
11,623 Added 5.01%
243,684 $77.6 Million
Q3 2017

Nov 08, 2017

BUY
$281.15 - $329.69 $65.2 Million - $76.5 Million
232,061
232,061 $72.7 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Amf Tjanstepension Ab Portfolio

Follow Amf Tjanstepension Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amf Tjanstepension Ab, based on Form 13F filings with the SEC.

News

Stay updated on Amf Tjanstepension Ab with notifications on news.